摘要:
The invention relates to compounds of formula: (I) or a salt or solvate thereof, wherein: R1 is —11CH2R5 or [18F]—C1-4 fluoroalkyl wherein R5 is hydrogen or C1-4 alkyl; R2 is hydrogen or C1-4 alkyl; R3 is halo; and R4 is halo, C1-4 alkylthio, or C1-4 alkyl; and their use for imaging central nervous system (CNS) receptors.
摘要翻译:本发明涉及式(I)化合物或其盐或溶剂化物,其中:R 1是 - (CH 2)CH 2 R 2, 或其中R 5为氢或C 1〜5的氟烷基,或其中R 5为氢或C 1-4烷基, -4 u>烷基; R 2是氢或C 1-4烷基; R 3是卤素; 且R 4为卤素,C 1-4烷基硫基或C 1-4烷基; 以及它们用于成像中枢神经系统(CNS)受体的用途。
摘要:
The invention provides use of a compound of formula (I): or a salt thereof, wherein: R1 is 125I, 124I, 123I, 75Br, 76Br, or 18F; R2 is C1-6 alkyl; and R3 is selected from hydrogen, C1-6 alkyl, —C(O)C1-6 alkyl, —C(O)C1-6 haloalkyl, and —C(O)CH(R4)NH2; wherein R4 is selected from hydrogen, C1-6alkyl, C1-6hydroxyalkyl, and C1-6aminoalkyl; for the manufacture of a radiopharmaceutical for the in vivo diagnosis or imaging of an amyloid-associated disease, particularly Alzheimer's disease.
摘要:
A method for coating the internal surfaces of a reaction vessel having a small internal diameter comprises the steps of (i) introducing into the reaction vessel a solution of one or more monomers in a suitable solvent; (ii) introducing a flow of an inert gas through the reaction vessel; and (iii) initiating polymerization of the monomer solution.
摘要:
The present invention provides novel tetracyclic indole compounds of Formula (I) either as in vivo imaging agents or as therapeutic agents. A method for the preparation of the in vivo imaging agent compound is also provided by the invention, as well as a precursor for use in said method. Pharmaceutical compositions comprising the compounds of the invention are additionally provided. Where the pharmaceutical composition comprises a compound suitable for in vivo imaging, a kit is provided for the preparation of the pharmaceutical composition. In a further aspect, use of the compound for in vivo imaging or treatment of conditions associated with PBR is provided.
摘要:
The present invention provides novel tetracyclic indole compounds of Formula (I) either as in vivo imaging agents or as therapeutic agents. A method for the preparation of the in vivo imaging agent compound is also provided by the invention, as well as a precursor for use in said method. Pharmaceutical compositions comprising the compounds of the invention are additionally provided. Where the pharmaceutical composition comprises a compound suitable for in vivo imaging, a kit is provided for the preparation of the pharmaceutical composition. In a further aspect, use of the compound for in vivo imaging or treatment of conditions associated with PBR is provided.
摘要:
The invention relates to in vivo imaging agents, specifically radiolabelled insulin derivatives of formula (III); wherein X is —CO—NH—, —NH—, —O—, —NHCONH—, or —NHCSNH—, and is preferably —CO—NH—, —NH— or —O—; Y is H, alkyl or aryl substituents; R* is a radiolabel moiety suitable for detection by SPECT or PET; and methods for preparing the same as well as their use in in vivo imaging methods.
摘要翻译:本发明涉及体内成像剂,特别是式(III)的放射性标记的胰岛素衍生物; 其中X是-CO-NH-,-NH-,-O-,-NHCONH-或-NHCSNH-,优选为-CO-NH-,-NH-或-O-; Y是H,烷基或芳基取代基; R *是适于通过SPECT或PET检测的放射性标记部分; 及其制备方法以及它们在体内成像方法中的应用。
摘要:
The invention relates to a process for the production of an [18F]fluorohaloalkane which comprises treatment of a solid support-bound precursor of formula (I): SOLID SUPPORT-LINKER-SO2—O—(CH2)nX (I) wherein n is an integer of from 1 to 7 and X is chloro, bromo or iodo; with 18F− to produce the [18F]fluorohaloalkane of formula (II) 18F—(CH2)n—X (II) wherein n and X are as defined for the compound of formula (I), optionally followed by (i) removal of excess 18F−, for example by ion-exchange chromatography; and/or (ii) removal of organic solvent.
摘要:
The invention relates to compounds of formula (I); wherein R1 and R2 independently selected from C1-6 alkyl; P1, P2, P3, and P4 are each independently hydrogen or a protecting group; and their use in the preparation of 18F-labelled 6-L-fluorodopa
摘要:
The invention relates to compounds of formula: (I) or a salt or solvate thereof, wherein: R1 is —11CH2R5 or [18F]—C1-4 fluoroalkyl wherein R5 is hydrogen or C1-4 alkyl; R2 is hydrogen or C1-4 alkyl; R3 is halo; and R4 is halo, C1-4 alkylthio, or C1-4 alkyl; and their use for imaging central nervous system (CNS) receptors.
摘要翻译:本发明涉及式(I)化合物或其盐或溶剂化物,其中:R 1是 - (CH 2)CH 2 R 2, 或其中R 5为氢或C 1〜5的氟烷基,或其中R 5为氢或C 1-4烷基, -4 u>烷基; R 2是氢或C 1-4烷基; R 3是卤素; 且R 4为卤素,C 1-4烷基硫基或C 1-4烷基; 以及它们用于成像中枢神经系统(CNS)受体的用途。
摘要:
The invention relates to a process for the production of an 18F-labelled tracer which comprises treatment of a solid support-bound precursor of formula (I): SOLID SUPPORT-LINKER-I+-TRACER (I) Y− wherein the TRACER is of formula (A): or an amine protected derivative thereof, wherein Y− is an anion, preferably trifluoromethylsulphonate (triflate) anion; and R1 is either (i) a group CH—NP1AP2A in which P1A and P2A are each independently hydrogen or a protecting group, or (ii) a carbonyl group; with 18F− to produce the labelled tracer of formula (II) or an amine protected derivative thereof, wherein R1 is as defined for the compound of formula (I).